Drug Shortage Report for FOSAVANCE
| Report ID | 35791 |
| Drug Identification Number | 02276429 |
| Brand name | FOSAVANCE |
| Common or Proper name | alendronate sodium / cholecalciferol tablets |
| Company Name | ORGANON CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ALENDRONIC ACID VITAMIN D3 |
| Strength(s) | 70MG 2800UNIT |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 4TAB BLIS |
| ATC code | M05BB |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2018-01-19 |
| Actual start date | 2018-01-11 |
| Estimated end date | 2018-02-09 |
| Actual end date | 2018-01-26 |
| Shortage status | Resolved |
| Updated date | 2018-01-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-844-820-5468 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2018-01-27 | English | Compare |
| v4 | 2018-01-26 | French | Compare |
| v3 | 2018-01-26 | English | Compare |
| v2 | 2018-01-12 | French | Compare |
| v1 | 2018-01-12 | English | Compare |
Showing 1 to 5 of 5